Targeting eosinophils in allergy, inflammation and beyond
Year: 2013
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd3838
Authors: Patricia C. Fulkerson, Marc E. Rothenberg
Institution: Cincinnati Children's Hospital Medical Center
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: U.S. Department of Defense, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: Immunobiology of Food Allergy and Its Treatment, Interleukin-13 in Experimental Asthma, A multi-center clinical trial of 1760 mcg of daily swallowed fluticasone vs. plac, Regulation of Gastrointestinal Eosinophils, IL-13 and Eosinophilic Esophagitis, THE HYPEREOSINOPHILIC SYNDROMES AND MEPOLIZUMAB, Eosinophil, Chemokine and IL-13 Cooperativity in Asthma, Regulation of Gastrointestinal Eosinophils, Role of Spi-C in eosinophil development and functional responses, IL-13 Associated Eosinophil Lung Responses, Epithelial Genes in Allergic Inflammation, Child Health Research Career Development Award (K1-Renewal Yrs 31-35)
OpenAlex ID: W2009016013